Kidney study for liver transplant patients with HRS
Part of Digestive system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how the kidneys are affected during a liver transplant in people with hepatorenal syndrome. It uses a small kidney sample (biopsy) taken during the transplant to understand changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been accepted for a liver transplant.
- You have a diagnosis of hepatorenal syndrome with acute kidney injury (HRS-AKI).
- You do not have a known kidney disease before this liver problem.
- You have two kidneys, not one.
- This is your first liver transplant, not a repeat.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who are getting a liver transplant (including repeat transplants) to monitor changes in their body using test results. It may help doctors understand how patients are doing after transplant and improve care over time.
This study checks new blood and urine tests to predict who with advanced liver scarring (cirrhosis) will develop hepatorenal syndrome, a serious kidney problem. The results may help doctors spot risk earlier, especially for people being referred for a liver transplant.
This trial studies kidney biopsies in people who had a liver transplant and then developed new signs of kidney damage. The goal is to better understand what’s causing the problem and how to guide next steps.
This study looks closely at kidney tissue after transplant to predict how well the organ will work over time. Researchers hope this will help improve long-term care for transplant recipients.
This study looks back at medical records of people who had hepatorenal syndrome (a type of kidney failure linked to liver disease) while in the hospital. The goal is to understand what treatments were used and how well patients did, which might help guide future care.
This study looks at how well a new blood test works to monitor kidney health after a transplant. It might help doctors catch problems early without needing a biopsy.
Hear when a new Liver Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.